Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from EGFR Specific Affibody for Diagnostic Detection and Therapeutic Targeting of Thyroid Cancer Cells. Local targets link to admitted publications; unresolved targets remain external evidence.
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
10.1016/j.drup.2023.100939 · 2023 · External reference
Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression
10.1007/s40618-019-01175-7 · 2020 · External reference
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
10.3390/cancers15174290 · 2023 · External reference
Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach
10.3389/fonc.2022.954759 · 2022 · External reference
Targeting endothelial growth factor receptor in thyroid cancer: current concepts and future directions
10.1007/s12032-025-02788-0 · 2025 · External reference
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks
10.1038/s41420-024-02157-2 · 2024 · External reference
Mechanisms of receptor tyrosine kinase activation in cancer
10.1186/s12943-018-0782-4 · 2018 · External reference
10.1002/mco2.446
10.1002/mco2.446 · 2023 · External reference
Therapeutic advances of targeting receptor tyrosine kinases in cancer
10.1038/s41392-024-01899-w · 2024 · External reference
Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications
10.3390/cells13010047 · 2023 · External reference
Petranovic Ovcaricek, P. Molecular Imaging and Theragnostics of Thyroid Cancers
10.3390/cancers14051272 · 2022 · External reference
Monoclonal antibody based radiopharmaceuticals for imaging and therapy
10.1016/j.currproblcancer.2021.100796 · 2021 · External reference
Advances in the strategies for designing receptor-targeted molecular imaging probes for cancer research
10.1016/j.jconrel.2019.04.030 · 2019 · External reference
Receptor targeted nuclear imaging of breast cancer
10.3390/ijms18020260 · 2017 · External reference
Next-Generation Molecular Imaging of Thyroid Cancer
10.3390/cancers13133188 · 2021 · External reference
10.1002/cmdc.201800624
10.1002/cmdc.201800624 · 2018 · External reference
Development of a ZHER3-Affibody-Targeted Nano-Vector for Gene Delivery to HER3-Overexpressed Breast Cancer Cells
10.1002/mabi.201900159 · 2019 · External reference
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
10.1038/s41419-020-2410-7 · 2020 · External reference
Affibody Molecules as Targeting Vectors for PET Imaging
10.3390/cancers12030651 · 2020 · External reference
Targeted Radionuclide Detection of Malignant Tumors Using Affibody
10.32607/actanaturae.27677 · 2025 · External reference
Affibody molecules as engineered protein drugs
10.1038/emm.2017.35 · 2017 · External reference
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
10.3390/biomedicines12051088 · 2024 · External reference
EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines
10.3892/ol.2018.8093 · 2018 · External reference
The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells
10.1016/j.bpj.2016.09.049 · 2016 · External reference
Affibodies as valuable tool to prevent β(2)m aggregation under lysosomal-like conditions
10.1186/s13062-025-00659-2 · 2025 · External reference
Engineering of a femtomolar affinity binding protein to human serum albumin
10.1093/protein/gzn028 · 2008 · External reference
High level expression and purification of recombinant flounder growth hormone in E. coli
10.1016/j.jgeb.2018.03.006 · 2018 · External reference
The Bradford method for protein quantitation
10.1007/978-1-59745-198-7_4 · 2009 · External reference
Differential miRNAs expression pattern of irradiated breast cancer cell lines is correlated with radiation sensitivity
10.1038/s41598-020-65680-z · 2020 · External reference
A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective antitumor activity
10.1016/j.ijbiomac.2022.08.150 · 2022 · External reference
I. CD34 + stem cell counting using labeled immobilized anti-CD34 antibody onto magnetic nanoparticles and EasyCounter BC image cytometer
10.1016/j.ab.2020.113929 · 2020 · External reference
A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency
10.1016/j.ejphar.2020.172912 · 2020 · External reference
Detergent binding explains anomalous SDS-PAGE migration of membrane proteins
10.1073/pnas.0813167106 · 2009 · External reference
Treatment outcomes in patients with papillary thyroid cancer undergoing radiofrequency ablation of metastatic lymph nodes
10.21037/gs-24-285 · 2024 · External reference
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
10.3389/fonc.2020.01249 · 2020 · External reference
A new paradigm for epidermal growth factor receptor expression exists in PTC and NIFTP regulated by microRNAs
10.3389/fonc.2023.1080008 · 2023 · External reference
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
10.3390/ijms22073663 · 2021 · External reference
Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
10.3389/fcell.2021.677867 · 2021 · External reference
Recent advances of affibody molecules in biomedical applications
10.1016/j.bmc.2024.117923 · 2024 · External reference
Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine
10.3389/fmolb.2023.1144817 · 2023 · External reference
An Affibody Molecule Is Actively Transported into the Cerebrospinal Fluid via Binding to the Transferrin Receptor
10.3390/ijms21082999 · 2020 · External reference
Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
10.3390/cells7100164 · 2018 · External reference
Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells
10.1021/acs.molpharmaceut.6b00919 · 2017 · External reference
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
10.1038/s41419-020-2410-7 · 2020 · External reference
ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway
10.1186/s12935-020-1098-1 · 2020 · External reference
Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens
10.3791/63927 · 2022 · External reference
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
10.2967/jnumed.118.216069 · 2019 · External reference
Generation of an anti-idiotypic affibody-based masking domain for conditional activation of EGFR-targeting
10.1016/j.nbt.2022.12.002 · 2023 · External reference
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
10.1093/protein/gzm011 · 2007 · External reference
Fusion of an EGFR-antagonistic affibody enhances the anti-tumor effect of TRAIL to EGFR positive tumors
10.1016/j.ijpharm.2022.121746 · 2022 · External reference
Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma
10.3390/cells13221823 · 2024 · External reference
